Urolithiasis

Fisang, C.; Anding, Ralf; Müller, Stefan; Latz, Stefan; Laube, Norbert

doi:10.3238/arztebl.2015.0083

Cited by 46 publications

(28 citation statements)

References 45 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Осмотр всей ЧЛС почки с использованием трансуретрального доступа стал возможен после разработки и внедрения в клиническую практику фиброуретероскопов с системой активного изгиба. Полный осмотр ЧЛС с помощью фиброуретероскопа осуществим у 94 % больных [34,35].…”

Section: лечениеunclassified

“…20 2 0 1 9 ANDROLOGY AND GENITAL SURGERY не во всех случаях возможно получить положительный результат -нередко требуются повторные сеансы дробления с предварительным дренированием ЧЛС. Данная процедура нередко осложняется макрогематурией, нарушением микроциркуляции паренхимы почки, угнетением ее функции [35]. В рекомендациях EAU и Российского общества урологов указано, что эндоскопические методы дробления могут применяться при любых конкрементах и позволяют достичь результата уже при 1-й процедуре.…”

Section: лечениеunclassified

See 1 more Smart Citation

Urolithiasis: etiopathogenesis, diagnosis and treatment

Nazarov

Ахмедов

Рычков

et al. 2019

Androl. genit. hir.

View full text Add to dashboard Cite

Urolithiasis is one of the leading places in the field of uropathology. The relevance of this topic is determined by the fact that every year the number of patients with urolithiasis is steadily increasing, both in the Russian Federation and in developed countries. According to most authors, that due to the increasing life expectancy, changes at the chemical composition of water, lifestyle and peculiarities of human nutrition, as well as global climate changes. Medico-economic and social significance of urolithiasis is that roughly 2 / 3 of patients who get sick are 30 to 60 years old. The disease is characterized by frequent relapses, high prevalence of complicated forms, in some cases leading to disability of the patient, which makes it difficult to treat. In spite of this, mortality from urolithiasis in the last few years has noticeably decreased, due to the active study of the etiopathogenesis of the disease, improvement of diagnostic methods, development and implementation of minimally invasive technologies in the treatment of urolithiasis. This literature review provides information on the prevalence of urolithiasis, the etiology and pathogenesis of stone formation in the urinary system, as well as main information of the most effective methods of diagnosis and treatment of urolithiasis at this time.

show abstract

Section: лечениеunclassified

Urolithiasis: etiopathogenesis, diagnosis and treatment

Nazarov

Ахмедов

Рычков

et al. 2019

Androl. genit. hir.

View full text Add to dashboard Cite

show abstract

“…Kidney stones are common in the ‘stone belt’ region, which extends over America (Southeast), Africa (North), Middle East Asia (Southeast), and Australia (Northeast). 1 Globally, the lifetime prevalence of stone disease is 10%–15% and accounts for millions of patient visits to emergency departments (ED) or outpatient clinics. 1 2 The acute painful presentation is commonly known as renal colic, and movement of stone in the urinary tract produces this excruciating pain.…”

Section: Introductionmentioning

confidence: 99%

What is the best analgesic option for patients presenting with renal colic to the emergency department? Protocol for a systematic review and meta-analysis

et al. 2017

View full text Add to dashboard Cite

IntroductionPatients with renal colic present to the emergency department in excruciating pain. There is variability in practice regarding the choice of initial analgesic to be used in renal colic. The aim of this article is to outline the protocol for review of the efficacy and safety of non-steroidal anti-inflammatory drugs (NSAIDs), opioids and paracetamol use in renal colic pain management.Methods and analysisThis is the protocol for a systematic review, comparing efficacy of NSAIDs, opioids and paracetamol in renal colic studied under randomised controlled trial (RCT) design. This protocol reporting is based on the PRISMA-P recommendations (PRISMA-P-checklist). We will conduct a comprehensive literature search for both peer-reviewed and grey literature published until 18 December 2016. Using a predefined search strategy, MEDLINE, Embase and Cochrane Central Register of Controlled Trials will be searched. Additional searches will include WHO International Clinical Trials Registry Platform, abstract list of relevant major conferences and the reference lists of relevant publications. Two authors will independently screen and identify the studies to be included. The RCT comparing NSAIDs versus opioids or paracetamol will be included in the review, if the age of participants in the study was >16 years and they presented with moderate to severe renal colic. Any disagreement between the screening authors will be resolved through discussion and reaching consensus; if not, a third reviewer will arbitrate. Quantitative data from homogeneous studies will be pooled in the meta-analysis using RevMan V.5.3 software. The findings of this review will be presented according to the guidelines in the Cochrane Handbook of Systematic Reviews of Interventions and the Preferred Reporting Items for Systematic Review and Meta-Analysis statement.Ethics and disseminationFormal ethics approval is not required, as primary data will not be collected. We plan to publish the result of this review in a peer-reviewed journal.

show abstract

“…Мочекаменная болезнь (уролитиаз) -одно из наиболее распространенных заболеваний почек и мочевыделительной системы как у мужчин, так и у женщин во всем мире [1,2,13]. В последние годы во многих развитых странах отмечается неуклонный рост заболеваемости уролитиазом от 5 до 15 % [4,12].…”

unclassified

“…Основные факторы, предрасполагающие к развитию уро-и нефролитиаза: климат региона проживания, особенности образа питания и питьевого режима, возраст, пол, наличие врожденных заболеваний мочевыделительной системы и приобретенных нарушений обмена веществ, применение различных медикаментов и др. [3,8,12,19].…”

unclassified

Testosterone replacement therapy in male urolithiasis patients with metabolic syndrome

Tagirov

2019

Pediatr (SPb)

View full text Add to dashboard Cite

Urolithiasis is one of the most wide-spread kidney lesions in males and females all over the world. It is particularly important for males with hypogonadism and metabolic syndrome. The goal of the study is to assess the effectiveness and safety of Testosterone replacement therapy in males with hypogonadism and metabolic syndrome. Patients and methods. 465 male urolithiasis patients were studied. Mean age was 46 (38-54 years). All patients involved in the study had excessive body mass and obesity of various extent. Mean body mass was 92 (85-97 kg) and body mass index 40.5. More than 50% of the patients had Ischaemic Heart Disease, Cholelithiasis and Goiter. Essential Hypertension was present in 76.3% of cases. In more than 50% of the cases there was a combination of two or three nosological forms present. Depending on the replacement therapy used all patients were distributed into two groups: the main (300 patients) and the control one (165 patients). Results of the study. Testosterone replacement therapy proved to contribute to normalization of mineral and lipid metabolism as well as improvement of kidney function and restoration of normal bone tissue density. Analysis of 5-year relapse frequency demonstrated it to be considerably lower in the main group (10%) than in the control one (30%) which is astatistically valid difference (p < 0.05). Conclusion. Testosterone replacement therapy is a highly effective and safe method for urolithiasis therapy in males with hypogonadism.

show abstract

Urolithiasis

Cited by 46 publications

References 45 publications

Urolithiasis: etiopathogenesis, diagnosis and treatment

Urolithiasis: etiopathogenesis, diagnosis and treatment

What is the best analgesic option for patients presenting with renal colic to the emergency department? Protocol for a systematic review and meta-analysis

Testosterone replacement therapy in male urolithiasis patients with metabolic syndrome

Contact Info

Product

Resources

About